1-4 of 4
Liam Fernyhough
Close
Sort by
Journal Articles

The Applicability of Tyrosine Kinase Inhibitors in Pediatric Chronic Myeloid Leukemia

Fateen Ata, Rola Ghasoub, Maria Benkhadra, Liam Fernyhough, Mahmood Aldapt, Nabil E. Omar, Abdulqadir Nashwan, Kamran Mushtaq, Mohamed A Yassin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6372.
https://doi.org/10.1182/blood-2023-179341
Published: 2023
Journal Articles

Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - a Systematic Review

Fateen Ata, Alaa Rahhal, Lujain Malkawi, Phool Iqbal, Ibrahim Khamees, Mousa A. AlHiyari, Zohaib Yousaf, Hana Qasim, Awni Alshurafa, Sundus Sardar, Saad Javed, Liam Fernyhough, Mohamed A. Yassin
Journal: Blood
Blood (2022) 140 (Supplement 1): 11127–11128.
https://doi.org/10.1182/blood-2022-158663
Published: 2022
Journal Articles

Chronic Myeloid Leukemia in Adolescents and Youngadults: Clinicopathological Variables and Outcomes

Mohammad Abdul-Jaber Abdulla, Mahmood B Aldapt, Prem Chandra, Susanna Jane Akiki, Liam Fernyhough, Sundus Sardar, Ammar Chapra, Abdulqadir Jeprel Nashwan, Mohamed A Yassin
Journal: Blood
Blood (2022) 140 (Supplement 1): 3911–3912.
https://doi.org/10.1182/blood-2022-171160
Published: 2022
Journal Articles

Lower-Dose Lenalidomide and Dexamethasone Reduces Toxicity without Compromising Efficacy In Patients with Relapsed/Refractory Myeloma, Who Are Aged ≥60 Years or Have Renal Impairment: Planned Interim Results of a Prospective Multicentre Phase II Trial

Hang Quach, MBBS, FRACP, FRCPA, MD, Liam Fernyhough, BMBS, BMediSci, FRACP, FRCPA, Ross Henderson, Gillian Corbett, Kevin Lynch, MBBS, David Ritchie, MBBS, FRACP, FRCPA, PhD, Simon J. Harrison, MD, PhD, H. Miles Prince, MBBS, FRACP, FRCPA, MD
Journal: Blood
Blood (2010) 116 (21): 1961.
https://doi.org/10.1182/blood.V116.21.1961.1961
Published: 2010